Jordan Julie
Chief Medical Officer
Jordan Julie has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Mar 30, 2026.
On the most recent filing, Jordan Julie is listed as Chief Medical Officer at Neurogene Inc. Inside the rolling window, Jordan Julie reported no open-market purchases and 1 open-market sale totaling $18K in NGNE.
Companies traded
Other insiders at NGNE
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$18K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Jordan Julie made?
Jordan Julie has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2026.
Which companies does Jordan Julie trade?
Jordan Julie has filed SEC Form 4 disclosures for 1 company, including NGNE.
When was Jordan Julie's most recent SEC Form 4 filing?
Jordan Julie's most recent SEC Form 4 filing on Tracefour is dated Mar 30, 2026.
What is Jordan Julie's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Jordan Julie is listed as Chief Medical Officer.
What is Jordan Julie's total buy and sell value in the current window?
Inside the rolling retention window, Jordan Julie bought $0 and sold $18K based on SEC Form 4 filings.
What was Jordan Julie's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 828 NGNE shares on 2026-03-26, worth $18K, per SEC Form 4 filings.